Organon (OGN) Inventory (2020 - 2026)
Organon (OGN) recorded quarterly Inventory of $1.4 billion in Q1 2026, down 2.35% quarter-over-quarter from $1.4 billion in Q4 2025, and up 0.81% on a YoY basis from $1.4 billion in Q1 2025.
Organon (OGN) Inventory (2020 - 2026) Analysis & Trends
Organon's Inventory history runs 7 years deep, the most recent figure standing at $1.4 billion for Q1 2026.
- In Q1 2026, Inventory rose 0.81% year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $1.4 billion (up 0.81% YoY), while the FY2025 annual figure was $1.4 billion, up 6.43% from the prior year.
- Inventory was $1.4 billion for Q1 2026 at Organon, down from $1.4 billion in the prior quarter.
- In the past five years, Inventory ranged from a high of $1.5 billion in Q3 2025 to a low of $879.0 million in Q3 2022.
- Historically, Inventory has averaged $1.2 billion across 5 years, with a median of $1.3 billion in 2024.
- The sharpest annual moves came in 2022 and 2023: Inventory dropped 4.25% in 2022, then soared 34.93% in 2023.
- A 5-year view of Inventory shows it stood at $1.0 billion in 2022, then soared by 31.11% to $1.3 billion in 2023, then rose by 0.46% to $1.3 billion in 2024, then advanced by 6.43% to $1.4 billion in 2025, then retreated by 2.35% to $1.4 billion in 2026.
- The last three Inventory figures came in at $1.4 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.5 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,026,132.38 Bn | 93,026,127.42 Bn | 7.76 Bn | 8.30 Bn |
| 2 | Eli Lilly | 1,022.62 Bn | 1,017.34 Bn | 16.22 Bn | 14.53 Bn |
| 3 | Johnson & Johnson | 570.65 Bn | 548.59 Bn | 15.96 Bn | 14.58 Bn |
| 4 | AbbVie | 398.73 Bn | 389.38 Bn | 10.78 Bn | 5.05 Bn |
| 5 | Merck | 295.53 Bn | 289.88 Bn | 12.09 Bn | 6.48 Bn |
| 6 | Amgen | 186.30 Bn | 174.26 Bn | 5.87 Bn | 6.19 Bn |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn | 1.91 Bn |
| 8 | Pfizer | 146.09 Bn | 133.32 Bn | -1.21 Bn | 10.67 Bn |
| 9 | Bristol Myers Squibb | 114.98 Bn | 104.53 Bn | 8.07 Bn | 2.76 Bn |
| 10 | Organon | 3.49 Bn | 2.37 Bn | 783.00 Mn | 1.37 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.37 Bn |
| Dec 31, 2025 | 1.41 Bn |
| Sep 30, 2025 | 1.49 Bn |
| Jun 30, 2025 | 1.45 Bn |
| Mar 31, 2025 | 1.36 Bn |
| Dec 31, 2024 | 1.32 Bn |
| Sep 30, 2024 | 1.38 Bn |
| Jun 30, 2024 | 1.29 Bn |
| Mar 31, 2024 | 1.26 Bn |
| Dec 31, 2023 | 1.32 Bn |
| Sep 30, 2023 | 1.19 Bn |
| Jun 30, 2023 | 1.20 Bn |
| Mar 31, 2023 | 1.12 Bn |
| Dec 31, 2022 | 1.00 Bn |
| Sep 30, 2022 | 879.00 Mn |
| Jun 30, 2022 | 950.00 Mn |
| Mar 31, 2022 | 946.00 Mn |
| Dec 31, 2021 | 915.00 Mn |
| Sep 30, 2021 | 918.00 Mn |
| Jun 30, 2021 | 871.00 Mn |